PAVmed Inc

PAVmed Inc Stock Forecast & Price Prediction

Live PAVmed Inc Stock (PAVM) Price
$1.78

2

Ratings

  • Buy 2
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$1.78

P/E Ratio

-0.09

Volume Traded Today

$105,600

Dividend

Dividends not available for PAVM

52 Week High/low

9.00/0.60

PAVmed Inc Market Cap

$9.1M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $PAVM ๐Ÿ›‘

Before you buy PAVM you'll want to see this list of ten stocks that have huge potential. Want to see if PAVM made the cut? Enter your email below

PAVM Summary

The PAVmed Inc (PAVM) share price is expected to increase by 461.8% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered PAVM. Price targets range from $4 at the low end to $22 at the high end. The current analyst consensus for PAVM is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

PAVM Analyst Ratings

PAVM is a stock in Health Care which has been forecasted to be worth $10 as an average. On the higher end, the forecast price is $22 USD by from and on the lower end PAVM is forecasted to be $4 by from .

PAVM stock forecast by analyst

These are the latest 20 analyst ratings of PAVM.

Analyst/Firm

Rating

Price Target

Change

Date

Ross Osborn
Cantor Fitzgerald

Neutral

$1.4

Reiterates

Aug 18, 2023
Ross Osborn
Cantor Fitzgerald

Neutral

$1.5

Downgrade

Jan 20, 2023
Frank Takkinen
Lake Street

Buy

$1.5

Maintains

Jan 18, 2023
Frank Takkinen
Lake Street

Buy

$5

Maintains

Aug 17, 2022

Cantor Fitzgerald

Overweight


Initiates

Mar 30, 2021

Ascendiant Capital

Buy


Initiates

Nov 5, 2020

Lake Street

Buy


Initiates

Oct 13, 2020

Maxim Group

Buy


Initiates

Jun 28, 2018

PAVM Company Information

  • Focus on Novel Products: PAVmed Inc. specializes in acquiring, developing, and commercializing innovative medical products targeting unmet needs in the U.S.
  • Lead Products:
    • CarpX: A patented, single-use, disposable device for minimally invasive treatment of carpal tunnel syndrome.
    • EsoCheck: A diagnostic test for early detection of esophageal precancer in patients with gastroesophageal reflux disease.
    • EsoGuard: A next-generation sequencing DNA assay for analyzing surface esophageal cells collected via EsoCheck.
  • Product Pipeline:
    • EsoCure: An esophageal ablation device for treating dysplastic Barrett's Esophagus.
    • PortIO: An implantable intraosseous vascular access device.
    • Veris: A cancer care platform aimed at improving patient outcomes.
  • Company History: Formerly known as PAXmed Inc., the company rebranded to PAVmed Inc. in April 2015 and was incorporated in 2014.
  • Headquarters: PAVmed Inc. is headquartered in New York, New York.
PAVM
PAVmed Inc (PAVM)

When did it IPO

2016

Staff Count

107

Country

United States

Sector/Industry

Healthcare/Medical Devices

CEO

Dr. Lishan Aklog M.D.

Market Cap

$9.1M

PAVmed Inc (PAVM) Financial Data

In 2023, PAVM generated $2.5M in revenue, which was a increase of 550.40% from the previous year. This can be seen as a signal that PAVM's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$0

Revenue From 2021

$500,000

0.00 %
From Previous Year

Revenue From 2022

$377,000

-24.60 %
From Previous Year

Revenue From 2023

$2.5M

550.40 %
From Previous Year
  • Revenue TTM $3.8M
  • Operating Margin TTM -1,397.8%
  • Gross profit TTM $-3,968,000
  • Return on assets TTM -80.1%
  • Return on equity TTM 275.9%
  • Profit Margin -161.8%
  • Book Value Per Share -7.70%
  • Market capitalisation $9.1M
  • Revenue for 2021 $500,000
  • Revenue for 2022 $377,000
  • Revenue for 2023 $2.5M
  • EPS this year (TTM) $-8.08

PAVmed Inc (PAVM) Latest News

No news data available.

...

PAVM Frequently asked questions

The highest forecasted price for PAVM is $22 from at .

The lowest forecasted price for PAVM is $4 from from

The PAVM analyst ratings consensus are 2 buy ratings, 0 hold ratings, and 0 sell ratings.